Cheng Du Sheng Nuo Biotec Co., Ltd.

Cheng Du Sheng Nuo Biotec Co., Ltd. has recently experienced an evaluation adjustment, reflecting changes in market perception based on technical indicators and financial metrics. The company reported a stable return on equity and significant profit growth, indicating a robust performance within the Pharmaceuticals & Biotechnology sector.

Cheng Du Sheng Nuo Biotec Co., Ltd. faced a notable decline in stock value, contrasting with the broader market's performance. Despite recent downturns, the company has shown significant growth over the past year. Financial metrics indicate a market capitalization of CNY 6,085 million and a price-to-earnings ratio of 52.00.

Cheng Du Sheng Nuo Biotec Co., Ltd. has shown notable stock activity, achieving an intraday high and reflecting strong performance in the pharmaceuticals sector. Over the past year, the company has significantly outperformed the China Shanghai Composite, with impressive returns and stable financial metrics, indicating robust growth potential.

Cheng Du Sheng Nuo Biotec Co. has demonstrated strong market performance, gaining 6.26% on September 30, 2025. Over the past year, it achieved a remarkable return of 113.23%, significantly outperforming the China Shanghai Composite. The company maintains a competitive edge, supported by substantial profit growth of 62.8%.